Passage of 2018 Farm Bill Strengthens cbdMD’s Persistence for CBD Industry Success

Share Article

cbdMD continues to pave the way for the CBD industry by educating, informing, and producing high-quality CBD oil products for the masses

“…cbdMD has been able to establish themselves as one of the most trusted brands in the industry. By focusing on their quality ingredients, competitive pricing, and personal customer support, cbdMD is quickly becoming a competitive force in the industry.”

As the beneficial properties of hemp derived CBD continue to become well-known, we expect that 2019 will hold many “firsts” for the industry. With the passing of the 2018 Farm Bill, signed Dec. 20 – which removed CBD as a Schedule 1 controlled substance– cbdMD LLC, a member of Level Brands, Inc. (NYSE American: LEVB) family of companies, has shown commitment to bringing awareness to the industry and their brand as a major player.

cbdMD, a CBD oil company that produces the industry’s highest quality CBD using innovative production and extraction techniques, has been dominating the marketing with its full line of organic THC-free products. Amy’s CBD Guide said, “…cbdMD has been able to establish themselves as one of the most trusted brands in the industry. By focusing on their quality ingredients, competitive pricing, and personal customer support, cbdMD is quickly becoming a competitive force in the industry.”

In December 2018, the Brightfield Group, a legal cannabis and CBD market research company, stated, “CBD is growing faster than cannabis in the U.S. and will soon be a $22 billion industry. It’s been flying under the radar but is set to explode having profound impacts on CPG [consumer packaged goods] and Pharma.”

cbdMD has already made news for being the first CBD company to be displayed on the Digital Billboard in Times Square on New Year’s Eve 2018 – the Big Apple’s busiest night of the year. cbdMD, subsidiary of Level Brands, is the first public CBD company to trade on the NYSE. cbdMD is also the official founder of National CBD Day; first CBD company to be featured in Rolling Stone Magazine; High Time’s #1 CBD Company in 2018; and Editor’s Choice for Entrepreneur Magazine’s Top 100 Cannabis Leaders Issue.

The company has also made huge strides with professional (and amateur) athletes as the first CBD company featured in Bellator MMA (represented by Gaston “The Dream Killer” Bolanos and Quinton “Rampage” Jackson); the first CBD company to take the podium for the Americas Rallycross (represented by Steve Arpin of Loenbro Motorsports and Hoonigan Racing); and a major sponsor for Nitro Circus, including the Nitro Circus You Got This Tour, Nitro World Games, and in humanitarian relief for #Race2Rebuild in Puerto Rico.

“It’s so exciting to witness the CBD industry flourish and break new boundaries,” said Caryn Dunayer, President of cbdMD. “The passing of the Farm Bill opens many new opportunities for us, and we will continue to push for more visibility and education in 2019.”

Dunayer adds, “I’m excited to see where cbdMD and the industry will be in another 365 days!”

About cbdMD (http://www.cbdMD.com)
cbdMD, a member of the Level Brands’ family of companies, offers a comprehensive line of 100% natural, hemp-derived CBD oil products, including tinctures, capsules, gummies, vape oils, bath bombs, topicals, and pet products. As a company committed to the highest standards for CBD sourcing, extraction, and production, cbdMD is for consumers seeking to experience the full benefits of CBD in a safe, convenient, and cost-effective manner. For more information, please visit http://www.cbdMD.com.

About Level Brands (http://www.levelbrands.com)
Level Brands is an innovative brand management and licensing company that provides bold, unconventional, and socially responsible branding for leading businesses. Following its acquisition of Cure Based Development, LLC in December 2018, through its wholly-owned subsidiary cbdMD LLC Level Brands owns and operates the nationally recognized consumer cannabidiol (CBD) brand cbdMD, whose current products include CBD gummies, CBD tinctures, CBD topical, CBD bath bombs, CBD oils, and CBD pet products. Level Brands' primary licensing and corporate brand management businesses target consumer products in the health and wellness space and other high-demand verticals, bringing innovative products to market under the kathy ireland® Health & Wellness; Ireland Men One (I'M1), and Encore Endeavor One (EE1) brands.

Forward-Looking Statements
This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as ''should,'' ''may,'' ''intends,'' ''anticipates,'' ''believes,'' ''estimates,'' ''projects,'' ''forecasts,'' ''expects,'' ''plans,'' and ''proposes.'' These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading "Risk Factors" in Level Brands, Inc.'s Annual Report on Form 10-K for the fiscal year ended September 30, 2018 as filed with the Securities and Exchange Commission (the "SEC") on December 12, 2018 and our other filings with the SEC. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are generally outside the control of Level Brands, Inc. and are difficult to predict. Level Brands, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Danielle
cbdMD
1 (800) 973-3984
Email >

Dave Gentry
RedChip Companies (Investors)
(407) 491-4498
Email >
Visit website